Oncotrace Cancer Monitoring
Waiting months between scans to learn whether your treatment is working takes a toll no patient should bear alone. SeeBeyond Medicine in Scarsdale, NY and Greenwich, CT offers Oncotrace liquid biopsy to track your cancer's response through a simple blood draw.
You deserve real-time answers. Oncotrace provides circulating tumor cell data between imaging appointments so you and your care team can act with confidence.
Schedule your Oncotrace consultation in Scarsdale, NY or Greenwich, CT
Credentials
Why SeeBeyond Medicine
Dr. Hyun Joon Lee founded SeeBeyond Medicine in 2006 with a single principle: test, don't guess. He holds triple board certification in Family Medicine, Integrative Holistic Medicine, and Obesity Medicine.
The practice has supported over 20,000 patients across Westchester and Fairfield County, including those navigating cancer treatment. Dr. Lee's integrative oncology approach pairs advanced diagnostics with whole-person care.
Our Scarsdale, NY office and Greenwich, CT office both offer Oncotrace cancer monitoring.
About This Service
What Is Oncotrace Cancer Monitoring?
Oncotrace is a liquid biopsy assay that isolates and quantifies circulating tumor cells (CTCs) from a peripheral blood sample. CTCs are cancer cells shed by primary or metastatic tumors into the bloodstream, and their enumeration provides a non-invasive biomarker for treatment response monitoring and early recurrence detection.
SeeBeyond Medicine uses Oncotrace to give patients a clearer picture of how their cancer is responding. A standard blood draw captures circulating tumor cells that conventional imaging cannot detect at early stages. This cellular-level data fills the gaps between scheduled scans.
Declining CTC counts often indicate that a treatment protocol is working. Rising counts signal the need for timely reassessment. Our integrative oncology team reviews every result within the context of your full care plan.
Conditions Treated
Patients in Active Treatment
Whether you are receiving chemotherapy, immunotherapy, or an integrative oncology protocol, Oncotrace tracks whether circulating tumor cell counts are declining. SeeBeyond Medicine shares these results with your oncology team to support collaborative treatment decisions.
Patients in Active Treatment
Whether you are receiving chemotherapy, immunotherapy, or an integrative oncology protocol, Oncotrace tracks whether circulating tumor cell counts are declining. SeeBeyond Medicine shares these results with your oncology team to support collaborative treatment decisions.
Survivors Monitoring for Recurrence
After completing treatment, the uncertainty of surveillance can weigh heavily. Oncotrace detects rising CTC levels earlier than standard imaging schedules allow. SeeBeyond Medicine recommends periodic liquid biopsy for patients with elevated recurrence risk.
Patients with a Family History of Cancer
Individuals with strong genetic predispositions or hereditary cancer syndromes use Oncotrace as part of proactive screening. Early detection remains one of the most important factors in outcomes.
Benefits
Non-Invasive Blood Draw
Non-Invasive Blood Draw
A single blood sample replaces the need for tissue biopsy in monitoring scenarios. Oncotrace minimizes physical discomfort during an already demanding treatment period. SeeBeyond Medicine makes the process as straightforward as routine lab work.
Answers Between Imaging Appointments
Months can pass between CT scans or MRI sessions. Oncotrace provides actionable data in those intervals, reducing the uncertainty that many patients describe as one of the hardest parts of cancer care.
Earlier Detection of Recurrence
Rising circulating tumor cell counts can appear before imaging findings or symptoms. This lead time gives your care team the opportunity to intervene sooner. SeeBeyond Medicine believes that information empowers patients.
What to Expect
Your Journey
01.
Oncotrace Cancer Monitoring at SeeBeyond Medicine
1. Compassionate Consultation Your physician listens to your cancer history, current treatment plan, and personal concerns. SeeBeyond Medicine determines whether Oncotrace monitoring fits your clinical situation and coordinates with your existing oncology team. 2. Blood Sample Collection A routine blood draw at our Scarsdale, NY or Greenwich, CT location provides the sample. The draw takes only a few minutes. No preparation or fasting is required. 3. Results Review and Care Coordination SeeBeyond Medicine reviews your circulating tumor cell data within the context of your full treatment picture. Your physician explains the findings clearly and discusses next steps. Monitoring frequency is adjusted based on your evolving needs.
02.
2. Blood Sample Collection
A routine blood draw at our Scarsdale, NY office or Greenwich, CT office provides the sample for analysis.
03.
3. Results and Treatment Adjustment
SeeBeyond Medicine reviews circulating tumor cell data and integrates findings into your oncology care plan. Monitoring frequency is adjusted based on results.
What Our Patients Say
Patient Experiences with Oncotrace Monitoring
Real stories from patients who found answers.
Patients who use Oncotrace monitoring at SeeBeyond Medicine frequently describe the reassurance of tracking their status through a straightforward blood draw rather than more invasive testing. Many appreciate that their physician reviews each result in the context of their overall treatment plan and takes the time to explain what the numbers mean for their next steps.
Oncotrace is one monitoring tool used alongside standard oncology assessment, not a stand-alone diagnosis, and results are always interpreted by a physician in the context of your full clinical picture. SeeBeyond Medicine evaluates each patient individually within established clinical guidelines.
Frequently Asked Questions
Common Questions
How often should I have Oncotrace testing during cancer treatment?
Monitoring frequency depends on your cancer type, treatment phase, and individual risk factors. SeeBeyond Medicine typically recommends testing every three to six months during active treatment. Your physician adjusts this schedule as your situation evolves.
Does Oncotrace replace CT scans or MRI imaging?
Oncotrace complements imaging; it does not replace it. Liquid biopsy adds circulating tumor cell data that imaging alone cannot provide. Together, these tools give your care team a more complete understanding of your cancer status.
Is the Oncotrace blood draw uncomfortable?
The draw is identical to routine blood work. Most patients describe it as brief and straightforward. SeeBeyond Medicine's clinical team ensures your comfort throughout the process.
Does insurance cover Oncotrace at SeeBeyond Medicine?
Coverage varies by plan and diagnosis. Our team verifies your benefits and provides clear cost information before scheduling. SeeBeyond Medicine also offers membership options that may reduce monitoring costs for ongoing care.
Related Services
Related Services
- High-Dose Vitamin C IV Therapy — provides immune and antioxidant support during integrative oncology care
- Mistletoe Cancer Therapy — an immunostimulatory therapy that complements cancer monitoring
- Integrative Oncology Program — the full-spectrum care framework that includes Oncotrace
Take the First Step
You Deserve Answers
Even if the waiting between scans feels overwhelming, Oncotrace liquid biopsy can provide the clarity you need to move forward with confidence. Healing is always possible, and knowledge is part of that path.
SeeBeyond Medicine's integrative oncology team is here to walk alongside you.
Schedule a Free Consultation at SeeBeyond Medicine in Scarsdale, NY or Greenwich, CT | Call: 914-722-9440